Suspected cancer: recognition and referral (NG12)Product type:GuidanceProgramme:NICE guidelineLast updated: 2 October 2023Published: 23 June 2015
Suspected neurological conditions: recognition and referral (NG127)Product type:GuidanceProgramme:NICE guidelineLast updated: 2 October 2023Published: 1 May 2019
Brain tumours (primary) and brain metastases in over 16s (NG99)Product type:GuidanceProgramme:NICE guidelineLast updated: 29 January 2021Published: 11 July 2018
Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer) (TA23)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 3 March 2016Published: 26 April 2001
Photodynamic therapy for brain tumours (IPG290)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 25 March 2009
Carmustine implants for the treatment of recurrent glioblastoma multiforme (terminated appraisal) (TA149)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 June 2008
Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma (TA121)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 27 June 2007
Improving outcomes for people with brain and other central nervous system tumours (CSG10)Product type:GuidanceProgramme:Cancer service guidelinePublished: 28 June 2006
Endoscopic transsphenoidal pituitary adenoma resection (IPG32)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 17 December 2003